Heiq Share Discussion Threads

[platts] 12/4/2021 14:11

share price currently a bit haphazard.

[ali47fish] 09/4/2021 22:30

thanks leaf i have also been adding a little at a time!

[leafysuburb] 09/4/2021 20:48

ali47fish, yes I have topped up and never quite caught the recent bottom but wasn't far away. 3 Publications have come out strongly in favour of the company in recent weeks and its track record of acquisition, business wins and new product launches speaks for itself. Its been a good week and I think it could strengthen a lot further. Good Luck whatever you decide.

[geraldus] 08/4/2021 08:07

Results on the 28th.I'm booked in for the InvestorMeet. Gla.

[ali47fish] 07/4/2021 10:37

leaf- i ve been watching this one and it was 198p early on and now it's up- so missed thelower sp? have you added?

[leafysuburb] 01/4/2021 16:08

Last few days the market shakers have been moving the share price down on impeccably low volume. Hopefully its gets to 190p to allow me a top up. 3 Magazines have now tipped the stock and what with all the deals announced since the turn of the New Year it should hopefully set up a good update later on the 21 April I believe.

[dr biotech] 27/3/2021 08:05

Is this the article? It’s free. Mostly charts, rather than an anything intrinsic about the company.

[dicktrade] 26/3/2021 15:10

likewise a subscriber to both, IC is not what it used to be and i dont enjoy the
new layout either, a lot harder to navigate and often filled with typos.
SCSW first class though.

[mrnumpty] 26/3/2021 14:47

DrBiotech . As a subscriber to both SCSW and IC , I agree - I much prefer the tips in SCSW but I also read IC in order to broaden my outlook .

[dr biotech] 26/3/2021 14:32

I think SCSW trumps IC in its tips. I've only been a subscriber a short time but his record - whilst containing some duffers - is pretty good.

[mrnumpty] 26/3/2021 14:26

As a long-term subscriber to Small Company Share Watch , I obviously noticed that Heiq was the front-page “ buy “ tip in this month’s ( March ) edition . At the moment I’m sitting on the sidelines . However , no one here seems to have noticed , or at least posted here , that Heiq is the subject of an article in today’s Investors’ Chronicle ( pages 72 & 73 ) . There’s an A4 page of text and an A4 page showing two share price graphs . As with a lot of Investors’ Chronicle , in my opinion at least , there’s so many caveats and counter arguments that the final analysis is ambiguous . However , the author sees £ 2.40 as a possible break out point . Good luck all and do your own research .

[miti 1000] 26/3/2021 06:38

Now, this is interesting. Girbau and HeiQ...

[geraldus] 19/3/2021 08:37

Yes,they have a solution for something that is ongoing.Like the numbers given that can be lacking in this type of deal.Gla

[jombaston] 19/3/2021 08:36

The key word in this release is 'royalty' - as the CEO stresses its high margin.

[2bluelynn] 19/3/2021 08:30

I think this share has the legs to fly over the next few months my biggest holding and adding .

[leafysuburb] 19/3/2021 07:49

The deal is a cracker. These are coming through at about 1 per week at the moment. Another new industry.

[metis20] 19/3/2021 07:36

From today's RNS
"The two companies have signed a five year contract (US$8m in the first two years, at which point the contract is subject to renewal) which is expected to deliver US$30m of royalty revenue to the Company.."

HEIQ's 1 HY2020 revenue was US$30m

and from the Jan 2021 trading update

"The Company expects to report that revenue for FY 2020 exceeded market expectations. This was due to a robust performance delivered by HeiQ's core portfolio of products, including a particularly strong sales performance from its antimicrobial technology, HeiQ Viroblock, which was launched during the Period. Since then, it has been applied to over 1 billion facemasks and won the Swiss Technology Award in Q4 2020."

[jammytass] 19/3/2021 07:19

pleased to announce that it has signed an Exclusive Licence and Chemicals Supply Agreement with ICP Industrial Inc, a division of ICP Group ("ICP"), the global leader in the development, application, and technical support of innovative thin film coatings which are applied to packaging used by the FMCG, pharmaceuticals and medical sectors.

The two companies have signed a five year contract (US$8m in the first two years, at which point the contract is subject to renewal) which is expected to deliver US$30m of royalty revenue to the Company ("the Minimum Exclusive Requirement") in exchange for exclusive worldwide rights to apply HeiQ Viroblock to coatings for printing processes such as commercial print, food, beverage and pharma packaging. ICP will market its products with the HeiQ Viroblock technology and trademarks to its downstream customers, which manufacture packaging products for some of the world's largest consumer brands. This will enable brand owners to market products packaged in materials with antimicrobial properties to consumers. The two companies are currently completing the product development, due to be finalized at the latest by 1st August 2021, following which the exclusivity period begins. HeiQ will supply ICP with HeiQ Viroblock, an antimicrobial technology proven to destroy over 99.99% of infectious viruses and bacteria within minutes, and will receive a percentage of ICP's net sales in the form of royalties, in line with its strategy to grow its high margin royalty and licensing business. The partnership enables HeiQ to bring its market leading antimicrobials and other HeiQ technologies into several new industry fields served by ICP.

HeiQ co-founder and CEO Carlo Centonze said:

"This multi-year agreement with a global print and packaging coating leader builds on our recent contract to apply HeiQ Viroblock to paint, demonstrating that HeiQ Viroblock and antimicrobial technology is becoming mainstream for all materials that we touch in our daily lives. It is with great pleasure that we team up with ICP Industrial Inc, a global leader which provides the print and packaging industry with advanced coating technologies. It is of paramount importance given that the global pandemic has shown that viruses can remain infectious on paper and cardboard for several days. These recent agreements relating to HeiQ Viroblock being adopted by businesses outside of the textile industry also highlight that our award-winning innovation has entered a new phase in its lifecycle and that the brand equity we have built as an innovation leader is delivering meaningful returns. Subject to a successful trial period, we believe that this royalty arrangement has the potential to deliver strong, high margin sales for HeiQ and to strengthen our brand equity significantly, through uptake by ICP's blue chip client base."

ICP Industrial's Division President Paul Grzebielucha said:

"We are excited to offer this new innovative life-saving technology to the print world. We have global reach under our brands of Nicoat, MinusNine and Hitech Coatings to provide this protection on billions of printed surfaces per year. This HeiQ Viroblock game changing technology for our industry and society has proven to be a superior solution that is currently available in the marketplace. HeiQ products have proven efficacy in terms of destroying infectious viruses in minutes rather than hours with an effective rate of 99.95%. ICP Industrial has always provided innovative solutions to the graphic arts and packaging segments while maintaining the highest level of customer and technical service in the industry. ICP Industrial is very excited about the partnership with HeiQ bringing this technology to market pro

[davemac3] 19/3/2021 07:06

That's a cracker!

[leafysuburb] 16/3/2021 11:41

Lee Cooper face masks with not only Virobloc but also Smart Temp technology

[leafysuburb] 14/3/2021 21:07

Berger Silk Breatheasy

[leafysuburb] 11/3/2021 18:56

Its more likely market makers as sellers could gain a lot more for their shares. But if it gives me the opportunity to add further I will. All these deals add up and they are beginning to flow. Just read a good write up in Shares Magazine hinting at a lot more coming.

[sphere25] 11/3/2021 14:53

One of the more interesting pieces of news today and setting up for a sequence of further bullish pieces to hit the wires. Clearly the market is expecting this type of news and alot more.

Having watched this one abit closer recently, noted there are sellers in size who sell into all bullish news, and are at it again today so nothing as yet to change the more bullish dial from a short term perspective.

Nipped in and out of this one, but getting more and more tempted to tuck some of these away for the longer term. There are some tasty numbers being presented here and it looks a speculative possibility that the puzzle all comes together beautifully.

Could be abit early on the entry price with these big sellers feeding shares in. Need to see where the big buyers come in to offset these sell orders being worked, but certainly getting a little bullish tingle with this company.


A little bullish tingle?

Red flag alert, red flag alert!

Get Trident on even higher alert!

All imo
DYOR

[leafysuburb] 11/3/2021 09:11

It highlights the versatility of the product with Virobloc widening its appeal from textiles to other substances and materials. First mover status that will get them noticed. Holding firm to see if they snare Akzo Nobel who own Dulux paints or Hempel who own Crown paints.

[metis20] 11/3/2021 08:57

"The agreement will deliver US$600,000 of revenue to HeiQ for the first year, during which Berger will have exclusivity in India, with potential for significant additional future revenues."

For an HEIQ income statement, see page of